該当箇所へ

ケーススタディ:Immatics社、Genedata BiologicsでT細胞受容体を用いた新たな免疫療法の研究開発をデジタル化

Instead of embarking on a costly and time-consuming software customization project, Immatics uses Genedata’s out-of-the-box functionality to streamline CGT processes and increase R&D efficiency. Genedata’s scientific consultants worked closely with Immatics to configure Immatics-specific CGT workflows and integrate laboratory instruments so rollout of the platform was straightforward – and fast.